[Participation of galaninergic brain structures in response to the systemic lipopolysaccharide administration].
Klimenko
V M
VM
Liudyno
V I
VI
Langel
U
U
Krasnova
I N
IN
Abdurasulova
I N
IN
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D019004:Galanin / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology / Q000031:analogs & derivatives; D006719:Homovanillic Acid / Q000378:metabolism; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000633:toxicity; D008297:Male; D015213:Neuroimmunomodulation / Q000502:physiology*; D010446:Peptide Fragments / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D044088:Receptors, Galanin; D018013:Receptors, Neuropeptide / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013373:Substance P / Q000494:pharmacology / Q000031:analogs & derivatives
D008070:Lipopolysaccharides; D010446:Peptide Fragments; D044088:Receptors, Galanin; D018013:Receptors, Neuropeptide; D015102:3,4-Dihydroxyphenylacetic Acid; C074975:galantide; D013373:Substance P; D019004:Galanin; D004298:Dopamine; D006719:Homovanillic Acid
Uchastie galaninergicheskikh struktur mozga v reaktsii na sistemnoe vvedenie lipopolisakharida.